Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report
Abstract Philadelphia chromosome‐positive acute myeloid leukemia (Ph + AML) is a rare type of AML with a low survival rate and poor prognosis. We first report a Ph + AML patient who remained in long‐term remission after the combination of flumatinib and venetoclax, which could provide corresponding...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.6688 |
| _version_ | 1811162553824313344 |
|---|---|
| author | Si‐Man Huang Tao Tao Chao‐Ling Wan Tian‐Mei Wu Han‐Yu Cao Yan Qiu Xiang‐Dong Shen Bin‐Ru Wang Shuai‐Shuai Ge Yan‐Yan Li Tong‐Tong Zhang Bing Wu Sheng‐Li Xue |
| author_facet | Si‐Man Huang Tao Tao Chao‐Ling Wan Tian‐Mei Wu Han‐Yu Cao Yan Qiu Xiang‐Dong Shen Bin‐Ru Wang Shuai‐Shuai Ge Yan‐Yan Li Tong‐Tong Zhang Bing Wu Sheng‐Li Xue |
| author_sort | Si‐Man Huang |
| collection | DOAJ |
| description | Abstract Philadelphia chromosome‐positive acute myeloid leukemia (Ph + AML) is a rare type of AML with a low survival rate and poor prognosis. We first report a Ph + AML patient who remained in long‐term remission after the combination of flumatinib and venetoclax, which could provide corresponding treatment ideas for clinical practice. |
| first_indexed | 2024-04-10T06:31:20Z |
| format | Article |
| id | doaj.art-ed773244ff8842be89b88a44e8235d72 |
| institution | Directory Open Access Journal |
| issn | 2050-0904 |
| language | English |
| last_indexed | 2024-04-10T06:31:20Z |
| publishDate | 2023-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical Case Reports |
| spelling | doaj.art-ed773244ff8842be89b88a44e8235d722023-03-01T07:50:56ZengWileyClinical Case Reports2050-09042023-01-01111n/an/a10.1002/ccr3.6688Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case reportSi‐Man Huang0Tao Tao1Chao‐Ling Wan2Tian‐Mei Wu3Han‐Yu Cao4Yan Qiu5Xiang‐Dong Shen6Bin‐Ru Wang7Shuai‐Shuai Ge8Yan‐Yan Li9Tong‐Tong Zhang10Bing Wu11Sheng‐Li Xue12National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou ChinaDepartment of Respiratory and Critical Medicine the Fifth People's Hospital of Suzhou Suzhou ChinaNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou ChinaNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou ChinaNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou ChinaNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou ChinaNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou ChinaNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou ChinaNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou ChinaNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou ChinaNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou ChinaSuzhou Hospital of Chinese Traditional Medicine the Affiliated Hospital of Nanjing University of Chinese Traditional Medicine Suzhou ChinaNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou ChinaAbstract Philadelphia chromosome‐positive acute myeloid leukemia (Ph + AML) is a rare type of AML with a low survival rate and poor prognosis. We first report a Ph + AML patient who remained in long‐term remission after the combination of flumatinib and venetoclax, which could provide corresponding treatment ideas for clinical practice.https://doi.org/10.1002/ccr3.6688flumatinibPhiladelphia chromosome‐positive acute myeloid leukemiaregimenvenetoclax |
| spellingShingle | Si‐Man Huang Tao Tao Chao‐Ling Wan Tian‐Mei Wu Han‐Yu Cao Yan Qiu Xiang‐Dong Shen Bin‐Ru Wang Shuai‐Shuai Ge Yan‐Yan Li Tong‐Tong Zhang Bing Wu Sheng‐Li Xue Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report Clinical Case Reports flumatinib Philadelphia chromosome‐positive acute myeloid leukemia regimen venetoclax |
| title | Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report |
| title_full | Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report |
| title_fullStr | Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report |
| title_full_unstemmed | Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report |
| title_short | Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report |
| title_sort | flumatinib plus venetoclax as an effective therapy for philadelphia chromosome positive acute myeloid leukemia a case report |
| topic | flumatinib Philadelphia chromosome‐positive acute myeloid leukemia regimen venetoclax |
| url | https://doi.org/10.1002/ccr3.6688 |
| work_keys_str_mv | AT simanhuang flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport AT taotao flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport AT chaolingwan flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport AT tianmeiwu flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport AT hanyucao flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport AT yanqiu flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport AT xiangdongshen flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport AT binruwang flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport AT shuaishuaige flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport AT yanyanli flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport AT tongtongzhang flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport AT bingwu flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport AT shenglixue flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport |